Sign inGet started

Ally Bridge Group Capital Partners II, L.P.

Insider CIK 1609313 · SRNE 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SRNE Sorrento Therapeutics, Inc S Sale2018-09-132018-09-1429,137$5.01 $146.0K1,091,697SEC↗
SRNE Sorrento Therapeutics, Inc S Sale2018-09-132018-09-1478,677$4.92 $387.1K1,013,020SEC↗
SRNE Sorrento Therapeutics, Inc S Sale2018-09-122018-09-14189,754$5.06 $960.2K1,120,834SEC↗
SRNE Sorrento Therapeutics, Inc S Sale2018-02-072018-02-08150,000$7.19 $1.08M1,328,529SEC↗
SRNE Sorrento Therapeutics, Inc S Sale2018-02-062018-02-08512,912$6.75 $3.46M1,478,529SEC↗
SRNE Sorrento Therapeutics, Inc S Sale2018-02-052018-02-0716,265$8.00 $130.1K1,310,588SEC↗
SRNE Sorrento Therapeutics, Inc S Sale2018-02-052018-02-0737,483$8.00 $299.9K3,041,759SEC↗
SRNE Sorrento Therapeutics, Inc S Sale2018-02-052018-02-0716,973$8.00 $135.8K1,408,027SEC↗
SRNE Sorrento Therapeutics, Inc S Sale2018-01-302018-01-3157,037$7.65 $436.3K1,425,000SEC↗
SRNE Sorrento Therapeutics, Inc S Sale2018-01-302018-01-3153,786$7.65 $411.5K1,326,853SEC↗
SRNE Sorrento Therapeutics, Inc S Sale2018-01-302018-01-31124,333$7.65 $951.1K3,079,242SEC↗
SRNE Sorrento Therapeutics, Inc S Sale2018-01-292018-01-3117,214$7.61 $131.0K1,380,639SEC↗
SRNE Sorrento Therapeutics, Inc S Sale2018-01-292018-01-3117,963$7.61 $136.7K1,482,037SEC↗
SRNE Sorrento Therapeutics, Inc S Sale2018-01-292018-01-3139,667$7.61 $301.9K3,203,575SEC↗
SRNE Sorrento Therapeutics, Inc P Buy2017-04-192017-04-21550,000$2.00 $1.10M1,991,441SEC↗
SRNE Sorrento Therapeutics, Inc P Buy2017-04-132017-04-171,500,000$2.00 $3.00M1,500,000SEC↗
SRNE Sorrento Therapeutics, Inc P Buy2017-04-132017-04-171,000,000$2.00 $2.00M1,397,853SEC↗
SRNE Sorrento Therapeutics, Inc J Other2017-01-052017-01-093,243,242— $03,243,242SEC↗
SRNE Sorrento Therapeutics, Inc J Other2017-01-052017-01-091,441,441— $01,441,441SEC↗
SRNE Sorrento Therapeutics, Inc J Other2017-01-052017-01-09397,853— $0397,853SEC↗